Insight

Melissa Loh: Healthcare utilization in leukaemia and myelodysplastic syndrome

Melissa Loh/X

Dec 19, 2024, 11:23

Melissa Loh: Healthcare utilization in leukaemia and myelodysplastic syndrome

Melissa Loh, Associate Professor at the University of Rochester Medical Center, shared on X:

“Extension of our prior work on healthcare utilization in leukaemia and myelodysplastic syndrome, we now also showed high cost at EOL.

MOLST form completion associated with lower cost.”

Melissa Loh

Portable medical orders and end-of-life measures in acute myeloid leukemia and myelodysplastic syndromes

Authors: Marissa LoCastro, Andrea M. Baran, Jane L. Liesveld, Eric Huselton, Michael W. Becker, Kristen Marie O’Dwyer, Omar S. Aljitawi, Megan Baumgart, Eric Snyder, Benzi Kluger, Kah Poh Loh, Jason H. Mendler

Melissa Loh

Andrea M. Baran Benzi Kluger cancer Eric Huselton Eric Snyder healthcare utilization Jane L. Liesveld Jason H. Mendler Kah Poh Loh Kristen Marie O’Dwyer leukaemia Marissa LoCastro Megan Baumgart Melissa Loh Michael W. Becker Myelodysplastic syndrome Omar S. Aljitawi OncoDaily Oncology

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity

Garo Armen - A Bold Call to Action: Embracing Real-Time Innovation in Pediatric Cancer

Black History Month 2025: Honoring Contributions to Oncology